How free market thinking has blocked climate action

In this episode of Talk of Iowa, host Charity Nebbe interviews Naomi Oreskes, historian and author of The Big Myth, about how free market ideology has obstructed meaningful climate action in the United States. Oreskes traces the roots of this narrative back over a century, showing how business interests systematically reframed government regulation as an attack on freedom—beginning with opposition to child labor laws and later weaponized during the Reagan era. She argues that this false dichotomy between freedom and government intervention has been used to block climate policies, despite overwhelming scientific consensus. The conversation also explores how industries like fossil fuels and agrochemicals have funded disinformation campaigns, including the ghostwriting of scientific papers to downplay the dangers of glyphosate (Roundup), and how regulatory capture continues to protect these industries. Oreskes emphasizes that history offers hope: successful actions like the ozone layer protection and DDT bans prove that science-based regulation works. The second half of the episode shifts to Dr. Wanakee Carr, a Black OBGYN in Des Moines, who discusses the crisis in rural reproductive healthcare in Iowa, the racial disparities in maternal mortality, and the importance of representation in medicine. She shares how her identity as a Black woman helps build trust with patients and inspires future generations, while also highlighting systemic barriers like funding shortages and restrictive legislation that hinder diversity in medicine. Key takeaways include: 1) Free market ideology has been strategically used to block environmental and public health regulations by framing them as threats to freedom; 2) Government intervention has historically enabled innovation and safety (e.g., the internet, ozone protection), contradicting the myth of unregulated markets; 3) Scientific integrity is under threat when industry funds biased research, as seen in the glyphosate controversy; 4) Representation in healthcare—especially for marginalized communities—improves patient outcomes and trust; 5) Systemic barriers like funding gaps and restrictive laws make it harder to attract and retain diverse medical professionals; 6) Historical successes in regulation prove that collective action can overcome powerful industry opposition; 7) Personal stories of resilience and purpose—like those of Oreskes and Dr. Carr—offer hope amid systemic challenges; 8) Citizens must advocate for legal rights and stronger regulatory systems to protect public health.